A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
Status:
Terminated
Trial end date:
2019-10-05
Target enrollment:
Participant gender:
Summary
Primary Objective: To assess local and generalized adverse events with repeat topical
application of 2% and 0.5% squaric acid dibutyl ester (SADBE) in subjects with frequent
herpes labialis (4 or more episodes in the previous 12 months).
Secondary Objective: To assess efficacy of repeat topical application of 2% and 0.5% SADBE in
the prevention of herpes labialis episodes.